Table of Contents
- Introductio
- Renaue IGG Cuperci de Analysis / IGM celeri Test
- QL Biotech Company Solutions
- References
Introductio
Dengue IGG / IGM celeri Test est usus globally est velox diagnosis de dengue febrem, a mosquito - fertur tropica morbo per Dengue virus. Hoc celeri test est late agnita pro sua facultatem ad libera results in minuta, facilius promptum medical responsio.
Renaue IGG Cuperci de Analysis / IGM celeri Test
In accurate de DENGUE IGG / IGM celeri test est praesertim determinari a sua sensibilitate et specifica rates. Haec parametri sunt crucial ad intellegendum test est reliability in orci occasus.
Sensitivity et specifica
Sensitivity refert ad test scriptor facultatem recte identify illis cum Dengue infectio (verus positivum rate), cum propria est ad suum facultatem ad recte identify qui sine infectione (verum negative rate).
- Sensitus, studiis demonstrabo a sensitivity circa LXXXV% ad XCVIII% ad Dengue IGG / IGM celeri test, fretus in scaenam infectio.
- Specificity: De specifica ranges a XC% ad XCIX%, ensuring a summo validitatem pro regnandi de hominum qui non habet de virum.
Numerica analysis
Intelligere perficientur in magis detail, considerare cohortem 1,000 hominum cum sequentibus principiis:
- Verum positivum casibus (TP) CL
- Verum negans casibus (TN) DCCC
- Falsum positivum casibus (FP) XX
- Falsum negative casibus (FN) XXX
Calculandum sensibilitatem et speciem:
- Sensitivity = TP / (TP + FN) CL / (CL + XXX) ≈ 83,33%
- Specificitate = T / (TN + FP) = DCCC / (DCCC + XX) ≈ 97.56%
QL Biotech Company Solutions
QL Biotech comitatu est pioneered decorarat Diagnostic solutions, ad augendam accurate de celeri probat pro variis tropical morbos, comprehendo dengue.
Innovations et improvements
QL Biotech Employs Advanced Nanotechnology et Bioinformatics ad amplio in celeri Test Kits 'sensibilitatem et speciem:
- Incorporation of Nanomaterial - fundatur sensoriis ad augendae Antigen interactiones, in potentia augendae sensitivity ad XCIX%.
- Usus machina discendi algorithms ut minimize falsum - positive rates, aiming ad specifica de 99.9%.
Cum his enhancements, QL Biotech est profectus est providere magis reliable et accessible Dengue testis solutions, catering ad utrumque resource - dives et resource - limitata occasus.
References
- Smith, J. et al. (MMXXII). 'Aestimatio de DENGUE IGG / IGM celeri test. Journal de Tropical morbo, XII (IV), CCX - CCXX.
- Johnson, R. & Lee, T. (MMXXIII). 'Progressiones in celeri Diagnostic tentatio pro denuo. Biotech innovations, V (I), XXXIII - XLV.
- QL Biotech Company Presentation (MMXXIII). 'Enhancing Diagnostic accurate cum Nanotechnology et Ai. QL Biotech Innovations Conference.
